Publications

Huang HH, Shen D, Chan TC, Cho, Y-T, Tang, C-H, and Chu C-Y. Topical Calcineurin Inhibitors and the Risk of Cancer among Patients with Atopic Dermatitis: A Nationwide, Population-based, Retrospective Cohort Study. Am J Clin Dermatol. 2023 Sep; 24(5):799–808. doi: 10.1007/s40257-023-00787-3.

Huang HH and Kai-Cheng Chang. Association between the use of glucagon-like peptide-1 agonist and the risk of psoriasis in diabetes patients compared to dipeptidyl peptidase-4 inhibitors in Taiwan. Poster presented at the 2023 ICPE of the International Society of Pharmacoepidemiology. Sep. 23–27, 2023. Halifax, Canada.

Huang HH, Po-Hsien Lu and Tzu-Cheng Tsai. Ralstonia Infection in Porphyria Patients with Port-A: a case report. Poster presented at the 5th Taiwan Joint Conference of Pharmacy and Pharmaceutical Sciences. Oct. 29–30, 2022. Taipei, Taiwan

Huang HH, and Kai-Cheng Chang. Association between the use of biological agents and the risk of cancer among patients with psoriasis. Poster presented at the 2022 American College of Clinical Pharmacy Global Conference. Oct. 15–18, 2022. San Francisco, the United States.